MIR661: A Potential Drug Or Biomarker (G724031)
MIR661: A Potential Drug Or Biomarker
MIR661, also known as hsa-mir-661, is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the mir gene family, which encodes for a family of transmembrane proteins that play important roles in cell signaling and development.
One of the unique features of MIR661 is its ability to interact with multiple signaling pathways, including TGF-β, NF-kappa-B, and PI3K/AKT. This makes it an attractive target for researchers looking for new drugs or biomarkers that can modulate these pathways.
MIR661 has also been shown to play a role in the regulation of cellular processes that are important for brain development and function, such as the formation of new neurons and the regulation of neurotransmitter release. This suggests that MIR661 may be a valuable drug or biomarker for the treatment of conditions such as Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders.
In addition to its potential role in neurodegenerative diseases, MIR661 has also been shown to be involved in a variety of other biological processes that are important for overall health and wellbeing. For example, it has been shown to play a role in the regulation of inflammation, immune response, and cell apoptosis.
MIR661 is also a good candidate for biomarker discovery in cancer, as it has been shown to be expressed in a variety of cancer types, including breast, lung, and ovarian cancer. This suggests that it may be a useful target for cancer immunotherapy, where the use of antibodies to target and destroy cancer cells is a promising approach to treatment.
In conclusion, MIR661 is a protein that has the potential to be a drug target or biomarker for a variety of conditions. Its ability to interact with multiple signaling pathways and its role in the regulation of important biological processes make it an attractive target for researchers looking for new treatments or biomarkers. Further research is needed to fully understand the role of MIR661 in biology and its potential as a drug or biomarker.
Protein Name: MicroRNA 661
The "MIR661 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR661 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR662 | MIR663A | MIR663AHG | MIR663B | MIR664A | MIR664B | MIR665 | MIR668 | MIR670 | MIR671 | MIR6715A | MIR6715B | MIR6716 | MIR6717 | MIR6718 | MIR6719 | MIR6720 | MIR6721 | MIR6722 | MIR6724-1 | MIR6726 | MIR6727 | MIR6728 | MIR6729 | MIR6730 | MIR6731 | MIR6732 | MIR6733 | MIR6734 | MIR6735 | MIR6736 | MIR6737 | MIR6738 | MIR6739 | MIR6740 | MIR6741 | MIR6742 | MIR6743 | MIR6744 | MIR6746 | MIR6747 | MIR6748 | MIR6749 | MIR675 | MIR6750 | MIR6751 | MIR6752 | MIR6753 | MIR6754 | MIR6755 | MIR6756 | MIR6757 | MIR6758 | MIR6759 | MIR676 | MIR6760 | MIR6761 | MIR6762 | MIR6763 | MIR6764 | MIR6765 | MIR6766 | MIR6767 | MIR6768 | MIR6769A | MIR6769B | MIR6770-1 | MIR6770-2 | MIR6770-3 | MIR6771 | MIR6772 | MIR6773 | MIR6774 | MIR6775 | MIR6776 | MIR6777 | MIR6778 | MIR6779 | MIR6780A | MIR6780B | MIR6781 | MIR6782 | MIR6783 | MIR6784 | MIR6785 | MIR6786 | MIR6787 | MIR6788 | MIR6789 | MIR6790 | MIR6791 | MIR6792 | MIR6793 | MIR6794 | MIR6795 | MIR6796 | MIR6797 | MIR6798 | MIR6799 | MIR6800
